Advanced Oncotherapy (FRA:R3I1) Additional Paid-In Capital : €78.64 Mil(As of Jun. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Advanced Oncotherapy Additional Paid-In Capital?

Advanced Oncotherapy's quarterly additional paid-in capital increased from Jun. 2021 (€73.82 Mil) to Dec. 2021 (€83.66 Mil) but then stayed the same from Dec. 2021 (€83.66 Mil) to Jun. 2022 (€78.64 Mil).

Advanced Oncotherapy's annual additional paid-in capital declined from Dec. 2019 (€71.31 Mil) to Dec. 2020 (€67.89 Mil) but then increased from Dec. 2020 (€67.89 Mil) to Dec. 2021 (€83.66 Mil).

Advanced Oncotherapy Additional Paid-In Capital Historical Data

The historical data trend for Advanced Oncotherapy's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy Additional Paid-In Capital Chart

Advanced Oncotherapy Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Additional Paid-In Capital

Get a 7-Day Free Trial

49.00

56.44

71.31

67.89

83.66

Advanced Oncotherapy Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Additional Paid-In Capital	Get a 7-Day Free Trial															67.31	67.89	73.82	83.66	78.64

Advanced Oncotherapy Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Advanced Oncotherapy Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Oncotherapy (FRA:R3I1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (FRA:R3I1) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Tenterden Street, Third Floor, London, GBR, W1S 1TE

Website

https://www.avoplc.com

Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.

Advanced Oncotherapy (FRA:R3I1) Headlines

No Headlines